Vertex Pharmaceuticals Inc. buy BMO Capital Markets
Start price
02.08.23
/
50%
€327.35
Target price
02.08.24
€355.55
Performance (%)
35.94%
End price
03.08.24
€445.00
Summary
This prediction ended on 03.08.24 with a price of €445.00. With a performance of 35.94% the BUY prediction by BMO_Capital_Markets was a big success. BMO_Capital_Markets has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | -6.410% | -6.410% | -12.633% |
| iShares Core DAX® | -6.016% | -4.595% | 1.274% |
| iShares Nasdaq 100 | 0.511% | 0.164% | 14.573% |
| iShares Nikkei 225® | -7.156% | -2.215% | 28.107% |
| iShares S&P 500 | -0.257% | -0.841% | 10.196% |
Comments by BMO_Capital_Markets for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at BMO Capital Markets from $385.00 to $389.00. They now have an "outperform" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Current prediction by BMO_Capital_Markets for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€349.95
05.08.25
05.08.25
€458.50
05.08.26
05.08.26
12.44%
06.03.26
06.03.26
Stopped prediction by BMO_Capital_Markets for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€379.90
20.12.24
20.12.24
€498.52
20.12.25
20.12.25
2.55%
21.12.25
21.12.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€413.40
31.05.24
31.05.24
€459.80
31.05.25
31.05.25
-6.79%
01.06.25
01.06.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€357.80
07.11.23
07.11.23
€388.11
07.11.24
07.11.24
30.65%
08.11.24
08.11.24